The Patent Finder
US

Devices, formulations, and methods for delivery of multiple beneficial agents

US 8,343,140 Lapsed on the fee record
OverviewFamilyAssignmentsSources & methods

Lapsed Jan 1, 2025 on the fee record · High confidence

Third maintenance fee unpaid; grace period ended.

Filed Feb 12, 2009 as application 12/378,341 · Granted Jan 1, 2013
Base term, 20 years from filing, plus 823 days of patent term adjustment (USPTO delay)
Today
Lapsed Jan 1, 2025
2009 2031
Clock starts
Feb 12, 2009
No longer in force
Jan 1, 2025
Granted
Jan 1, 2013
Term would have run to
May 16, 2031
base term patent term adjustment after the term ends fee events Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
823
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

Its term would have run to May 16, 2031: its 20-year base term plus 823 days of term adjustment for prosecution delay. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Feb 12, 2009, when this application, 12/378,341, was filedFeb 12, 2029High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+823 days, USPTO patent term adjustment recordMay 16, 2031High confidence
Terminal disclaimer capNone on recordno cap appliedHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidlapsed Jan 1, 2025High confidence
Computed term endThe steps above, in orderJan 1, 2025High confidence

This family

US 8,343,140this patent
Jan 2025
Jan 2025
US 8,926,595In force
Sep 2029
Sep 2029
US 9,572,889Lapsed on the fee record
Feb 2025
Feb 2025
Application 15/362,240Abandoned
not computed
not computed
US 10,441,528In force
Feb 2029
Feb 2029
Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Apr 24, 2009
Reel 22593, frame 393
Alessi, Thomas R.; Leung, Karling Alice; Mercer, Ryan D.; Negulescu, Cristina G.; Rohloff, Catherine M.; Yang, BingIntarcia Therapeutics, Inc.Assignment of Assignor's Interest
Sep 8, 2010
Reel 24953, frame 525
Intarcia Therapeutics, Inc.Oxford Finance Corporation; Silicon Valley BankSecurity Agreement
Sep 8, 2010
reel/frame not recorded
Intarcia Therapeutics, Inc.Oxford Finance CorporationSecurity Agreement
Sep 8, 2010
reel/frame not recorded
Intarcia Therapeutics, Inc.Silicon Valley BankSecurity Agreement
Sep 23, 2011
Reel 26962, frame 62
Oxford Finance Corporation; Silicon Valley BankIntarcia Therapeutics, Inc.Release of Security Interest
Nov 14, 2012
Reel 29299, frame 678
Intarcia Therapeutics, Inc.U.S. Bank National Association, as Collateral AgentSecurity Agreement
Oct 23, 2015
Reel 36942, frame 544
U.S. Bank National Association, as Collateral AgentIntarcia Therapeutics, Inc.Release of Security Interest
Oct 9, 2019
Reel 50673, frame 20
Intarcia Therapeutics, Inc.; Intarcia Ireland LimitedMidcap Financial Trust, As AgentSecurity Interest
Oct 23, 2019
Reel 50801, frame 267
Intarcia Therapeutics, Inc.Baupost Private Investments Bviv-3, L.L.C., as Collateral AgentSecurity Interest
Jan 29, 2020
Reel 51739, frame 453
Baupost Private Investments Bviv-3, L.L.C. as Collateral AgentIntarcia Therapeutics, Inc.Release of Security Interest
Apr 17, 2020
Reel 52433, frame 1
Midcap Financial Trust, As AgentIntarcia Therapeutics, Inc.; Intarcia Ireland LimitedRelease of Security Interest
Apr 17, 2020
reel/frame not recorded
Midcap Financial Trust, As AgentIntarcia Therapeutics, Inc.Release of Security Interest
Apr 17, 2020
reel/frame not recorded
Midcap Financial Trust, As AgentIntarcia Ireland LimitedRelease of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited